Company Long-Term Loans and Borrowings: Amneal Pharmaceuticals Inc (AMRX)

Public company logo of Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals (AMRX) demonstrates immunity to economic crises due to stable demand for affordable medications. The company's current level of long-term debt on the GURU.Markets base chart contains data where the value of 2.53 expresses the metric level. Manufacturing plants in the US and India provide reliability, while the resilience of B2B ties with pharmacies guarantees the preservation of market positions even under regulatory pricing pressure.

AMRX Amneal Pharmaceuticals Company Long-Term Debts (07/04/2022 - 11/01/2026)

Summary analytical data breakdowns for Amneal Pharmaceuticals Inc (AMRX)

- market price and analyst price targets:
Stock Price amneal.com|AMRX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Amneal Pharmaceuticals|AMRX - Total Company Value
- book capitalization information:
Accounting Value per Share Amneal Pharmaceuticals|AMRX - Book Capitalization|Market Capitalization to Book Value Ratio amneal.com|AMRX - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Amneal Pharmaceuticals|AMRX - Long-Term Debt to Equity|Current Liabilities to Capital Amneal Corp|AMRX - Company Total Debt|Debt to Book Capital Amneal Pharmaceuticals|AMRX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Amneal Pharmaceuticals|Immediate Liquidity amneal.com
- earnings and multiples data:
AMRX - Company Net Income
Fundamental company valuation:amneal.com AMRX
Brand item of Amneal

Minimizing debt risks during the fundamental analysis of Amneal Pharmaceuticals (AMRX) requires assessing the company's ability to service its obligations, particularly when utilizing external production and logistics outsourcing. Monitoring the enterprise's long-term debt allows for the measurement of the total volume of loans with maturities exceeding one year, determining financial stability and the cost of borrowed capital within the balance sheet structure.

Who Amneal Pharmaceuticals competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|PRGO (Perrigo Company plc) - Company Long-Term Debts|Company Long-Term Debts alvotech.com|Company Long-Term Liabilities LQDA (Liquidia)|GLPG (Galapagos N.V.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ANI Pharma ANIP|Afrezza (MNKD) - Long-Term Debt|AMPH: Company Long-Term Liabilities|pacira.com - Amount of Long-Term Liabilities|SPRY: Company Long-Term Debts|Theravance Biopharma Inc - Company Long-Term Loans and Borrowings|AQST (Aquestive Pharma) - Company Long-Term Debts|Long-Term Debt scPharma SCPH|Company Long-Term Debt Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SXTC (China SXT Pharmaceuticals, Inc.)|Company Long-Term Debts Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Company Long-Term Debt|Invizyne (EXOZ) - Company Long-Term Liabilities|oramed.com (ORMP) - Company Long-Term Debt|Company Long-Term Indebtedness ENTX|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|Long-Term Debt ABVC BioPharma Inc. ABVC|Company Long-Term Debts CPIX|Company Long-Term Debts Quantum BioPharma Corp (QNTM)|Company Long-Term Debt FibroGen, Inc. FGEN|telomirpharma.com - Company Long-Term Debt|RANI: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Company Long-Term Debt|Long-Term Liabilities LEXX (Lexaria Bioscience Corp.)|PULM (Pulmatrix, Inc.) - Company Long-Term Debts|PTHL: Company Long-Term Loans and Borrowings|Company Long-Term Debts APM|Company Long-Term Debts Lyra Therapeutics Inc. (LYRA)|Company Long-Term Debt Impact BioMedical Inc IBO|Company Long-Term Loans and Borrowings TNFA|YCBD - Company Long-Term Debt|painreform.com (PRFX) - Company Long-Term Liabilities|CYTO: Company Long-Term Debts|Lipella Pharmaceuticals Inc (LIPO) - Company Long-Term Debts|OPTN (Optinose) - Company Long-Term Debts|Company Long-Term Liabilities Pieris Pharma (PIRS)|Company Long-Term Debts PROC|PTPI - Long-Term Debt|Qilian International Holding - Company Long-Term Liabilities|Company Long-Term Debts Acelyrin Inc. SLRN|TFFP: Company Long-Term Liabilities